Aug 6, 2026 04:20PM
Jul 10, 2026 05:44AM
Jun 2, 2026 06:19AM
May 7, 2026 06:05AM
Apr 29, 2026 07:01AM
Mar 17, 2026 10:12AM
Mar 17, 2026 07:34AM X4 Pharmaceuticals (XFOR) Misses Q4 EPS by 22c
Mar 9, 2026 06:40AM
Feb 27, 2026 07:03AM
Dec 5, 2025 02:58AM
Nov 10, 2025 06:50AM
Nov 5, 2025 04:12PM
Nov 5, 2025 12:17PM
Sep 17, 2025 07:13AM X4 Pharmaceuticals cuts workforce 50% to save $13 million annually
Sep 10, 2025 04:21PM
Aug 29, 2025 07:17AM
Aug 25, 2025 08:16AM
Aug 13, 2025 06:55AM
Aug 12, 2025 03:38PM
Aug 12, 2025 07:01AM
Jun 16, 2025 08:02AM X4 Pharmaceuticals (XFOR) Presents Positive Phase 2 Chronic Neutropenia Trial Data
Jun 10, 2025 08:02AM
May 2, 2025 07:28AM
May 1, 2025 06:30AM
Apr 24, 2025 08:01AM
Mar 27, 2025 06:40AM
Mar 26, 2025 06:45AM
Mar 25, 2025 02:25PM X4 Pharmaceuticals (XFOR) PT Lowered to $3 at Stifel
Mar 25, 2025 10:56AM
Mar 25, 2025 06:10AM
Feb 19, 2025 07:35AM
Feb 6, 2025 07:35AM
Jan 29, 2025 02:48PM
Jan 24, 2025 07:38AM
Jan 13, 2025 07:35AM X4 Pharmaceuticals (XFOR) and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand
Nov 14, 2024 07:00AM
Nov 13, 2024 04:00PM
Nov 13, 2024 06:24AM
Nov 13, 2024 06:07AM
Aug 8, 2024 06:08AM
Aug 7, 2024 09:54AM
Jun 28, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on X4 Pharmaceuticals (XFOR)
Jun 27, 2024 04:00PM
Jun 27, 2024 03:49PM
Jun 27, 2024 06:30AM

456,289 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All